| Ribosome |
61 |
4.07805E–34 |
| Cell adhesion molecules (CAMs) |
32 |
9.77704E–08 |
| Leukocyte transendothelial migration |
26 |
4.48439E–07 |
| Hematopoietic cell lineage |
22 |
1.39848E–06 |
| T cell receptor signaling pathway |
22 |
1.29348E–05 |
| TNF signaling pathway |
22 |
2.03368E–05 |
| Natural killer cell mediated cytotoxicity |
23 |
2.25268E–05 |
| Primary immunodeficiency |
12 |
2.61825E–05 |
| Chemokine signaling pathway |
29 |
0.000114141 |
| Cytokine-cytokine receptor interaction |
32 |
0.000162524 |
| B cell receptor signaling pathway |
13 |
0.003675118 |
| Platelet activation |
18 |
0.008715247 |
| NF-kappa B signaling pathway |
14 |
0.012230956 |
| Chagas disease (American trypanosomiasis) |
16 |
0.015394733 |
| Osteoclast differentiation |
17 |
0.02912761 |
| Mineral absorption |
8 |
0.034992874 |
| Toll-like receptor signaling pathway |
14 |
0.0359839 |
| Complement and coagulation cascades |
11 |
0.036881797 |
| Antigen processing and presentation |
11 |
0.039954575 |
| Measles |
17 |
0.041359224 |
| Spliceosome |
16 |
0.041531247 |
| Tight junction |
12 |
0.044963824 |
| ECM-receptor interaction |
12 |
0.044963824 |
